⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Invesco India Manufacturing Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | Invesco MF | HDFC MF |
| Category | Equity - Thematic Fund - Other | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹11.62 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★ | ★★★★★ |
| Benchmark | Nifty India Manufacturing - TRI | BSE Health Care - TRI |
| Fund Manager | Nikhil Kale | Nikhil Mathur |
| Inception | 14 Aug 2024 | 04 Oct 2023 |
| Returns | ||
| 1Y | 12.13% | 22.64% |
| 3Y | — | 30.41% |
| 5Y | — | — |
| Since Inception | 7.53% | 29.15% |
| Risk | ||
| 17.69 | 14.07 | |
| 0.99 | 0.59 | |
| 0.21 | 1.59 | |
| 5.57 | 21.67 | |
| 0.38 | 3.48 | |
| -12.75% | -9.23% | |
| Costs | ||
| Expense Ratio | 1.16% | 1.03% |
| Exit Load | 0.50% on or before 3M, Nil after 3M | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹100 | ₹100 |
| Min Lumpsum | ₹1,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
Invesco MF94%
HDFC MF94%
6.2%Only 6.2% of holdings by weight are common between Invesco MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingInvesco MFHDFC MF
Divi's Laboratories Ltd.3.85%9.39%
Sun Pharmaceutical Industries Ltd.2.39%8.28%
Category context: Equity vs Equity. Open the full Screener →